- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
- S-1 IPO registration
- 1.1 Form of Underwriting Agreement
- 3.1 Articles of Organization
- 3.2 Second Amended and Restated Operating Agreement
- 3.3 Form of Certificate of Incorporation
- 3.4 Form of Bylaws
- 3.5 Form of Articles of Incorporation of Apl Conversion Corp
- 3.6 Form of Bylaws of Apl Conversion Corp
- 3.7 Form of Articles of Conversion
- 3.8 Form of Plan of Conversion
- 3.9 Form of Certificate of Merger - Delaware
- 3.10 Form of Articles of Merger - Virginia
- 3.11 Form of Agreement and Plan of Reorganization
- 4.2 Form of Representative's Warrant
- 4.3 Form of Warrant to Purchase Membership Units (2011 Offering)
- 4.4 Form of Warrant to Purchase Membership Units (2013 Offering)
- 4.5 Form of Common Stock Purchase Warrant
- 4.6 Form of 2016 Convertible Promissory Note
- 4.7 Senior Secured Promissory Note
- 4.8 Form of Membership Unit Award (Profits Interest) Agreement
- 4.9 Option Agreement
- 4.10 Performance Bonus Plan
- 4.11 Form of 2017 Equity Incentive Plan
- 4.12 Form of Stock Option Grant Notice, Option Agreement
- 4.13 Form of Option Agreement
- 10.1 License Agreement
- 10.2 Amendment #1 to License Agreement
- 10.3 Amendment #2 to License Agreement
- 10.4 Amendment #3 to License Agreement
- 10.5 Executive Employment Agreement
- 10.6 Salary Forbearance Agreement
- 10.7 Consulting Agreement - Joseph Truluck
- 10.8 Termination Agreement
- 10.9 Securities Purchase Agreement
- 10.10 Security Agreement
- 10.11 Settlement Agreement and Release of Claims
- 10.12 Promissory Note
- 10.13 Form of Subscription Agreement
- 10.14 Consulting Agreement
- 10.15 Employment Agreement - William B. Stilley
- 10.16 Employment Agreement - Joseph Truluck
- 10.17 Employment Agreement - Tomasz H. Zastawny
- 10.18 Form of Indemnification Agreement
- 10.19 Sublease Agreement
- 10.20 Amendment #4 to License Agreement
- 23.1 Consent of Friedman LLP
- 23.3 Consent of Ipsos-insight, LLC
Exhibit 10.20
AMENDMENT #4 TO
LICENSE AGREEMENT
This Amendment #4, dated as of August 15, 2017 (this “Agreement”), to the Original License Agreement (as defined below) is by and between the University of Virginia Patent Foundation d/b/a the University of Virginia Licensing and Ventures Group, a Virginia not-for-profit corporation of the Commonwealth of Virginia, having its principal offices at 722 Preston Avenue, Suite 107, Charlottesville, VA 29903 (“UVA LVG”), and ADial Pharmaceuticals, LLC,a Virginia limited liability company (“Adial” and together with “UVA LVG”, the “Parties”).
WHEREAS, the Parties have entered into that certain licensing agreement dated as of January 21, 2011 and as amended on October 21, 2013, and as further amended on May 18, 2016 and March 27, 2017 (together, “Original License Agreement”); and
WHEREAS, the Parties wish to amend the Original License Agreement as provided herein.
NOW, THEREFORE in consideration of the premises set forth above and the mutual covenants set forth below, the parties hereto agree as follows:
AGREEMENT
1. The date in Section 4.2 B. is changed to December 31, 2023.
2. The date in Section 4.2 C. is changed to December 31, 2024.
3. Except as provided herein, the terms and obligations of the Parties under the Original License Agreement shall remain as specified therein.
IN WITNESS WHEREOF, the Parties have entered into this Agreement as of the date first written above.
University of Virginia Patent Foundation d/b/a the University of Virginia Licensing and Ventures Group | ADial Pharmaceuticals, LLC | |||
By: | /s/ Michael P. Straightiff | By: | /s/ William Stilley | |
Name: | Michael P. Straightiff Executive Director | Name: William Stilley, CEO Date: August 15, 2017 | ||
Date: | 08/18/2017 | |||
By: | /s/ Peter M. Grant, II | |||
Name: | Peter M. Grant, II Chair, Board of Directors | |||
Date: | 8/18/2017 |